Serum-free medium additive for improving CHO cell recombinant antibody expression and application
By adding leupeptin to the serum-free medium of CHO cells, the expression of recombinant antibodies in CHO cells was increased, the problem of insufficient yield of biological products in the prior art was solved, and the production cost was achieved. Effect.
Patent Information
- Application Number
- CN202411114600.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to effectively increase the expression of recombinant antibodies in CHO cells, affecting the yield of biological products.
Leptopeptin was used as a serum-free medium additive, with a final concentration of 30 μM to 360 μM. It was used in the suspension culture of CHO cells, which significantly increased the expression of recombinant antibodies in CHO cells.
Compared with the control without adding leopeptin, the relative expression of CHO cell biological products after adding leopeptin is increased by more than 1.76 times, and it does not affect the normal growth of cells and reduces the production cost of biological products.
Smart Images

Figure CN119082041A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and particularly relates to a serum-free culture medium additive for improving the expression of recombinant antibodies in CHO cells and an application thereof. Background Art
[0002] Chinese hamster ovary cells, or CHO cells, can be cultured either adherently or in suspension, have the advantages of high cell density and high safety, can produce secretory proteins, and have complete post-translational modification capabilities. At the same time, CHO cells themselves rarely secrete endogenous proteins, which is very beneficial for the separation and purification of target proteins. With the rapid development of the biopharmaceutical industry, recombinant therapeutic proteins including antibodies have been widely used in medical diagnosis and treatment. At present, 80% of the antibody drugs approved for marketing are expressed by CHO cells, and CHO cells have become a widely used cell line in bioengineering.
[0003] Cell culture medium provides nutrition for cells and basic substances that promote their reproduction and proliferation. It is very important for cell growth and production. It includes conventional culture medium and serum-free culture medium. At present, CHO cells that produce recombinant vaccines and recombinant antibodies often need serum-free culture medium for culture. Therefore, in order to increase the production of recombinant vaccines and recombinant antibody biological products, the key is to increase the expression of recombinant vaccines and recombinant antibodies in CHO cells. Summary of the invention
[0004] The purpose of the present invention is to provide a serum-free medium additive and application for improving the expression of recombinant antibodies in CHO cells, wherein the additive is leupeptin. Leupeptin has a simple composition and is applied to CHO cell culture as a serine protease inhibitor to increase the expression of recombinant vaccines and recombinant antibodies in CHO cells, thereby increasing the yield of recombinant vaccines and recombinant antibody biological products.
[0005] The technical solution adopted by the present invention is a serum-free culture medium additive for improving the expression of recombinant antibodies in CHO cells. The additive is leupeptin, and its final concentration in the serum-free culture medium is 30 μM to 360 μM.
[0006] The serum-free medium is any one of CHO Pro Exp serum-free medium, HyCell CHO Medium and EXCELLCD CHO Fusion.
[0007] The leupeptin is used to increase the expression level of biological products in CHO cells, and the biological products are recombinant vaccines or recombinant antibodies.
[0008] Compared with the control without the addition of leupeptin, the addition of leupeptin increased the relative expression level of the CHO cell biological product by more than 1.76 times.
[0009] The leupeptin was added on day 0 of the CHO cell suspension culture.
[0010] When CHO cells are cultured in suspension, the concentration of leupeptin in the serum-free culture medium is 30 μM to 360 μM.
[0011] Preferably, the concentration of leupeptin is 30 μM to 120 μM.
[0012] An application of a serum-free culture medium additive for improving the expression of CHO cell recombinant antibodies, characterized in that the CHO cell recombinant antibody is adalimumab.
[0013] The method for increasing the expression level of adalimumab in CHO cells comprises the following steps:
[0014] Step 1: Cell recovery of adalimumab high-expressing monoclonal cell line.
[0015] Step 2: Adhesion culture of monoclonal cells with high adalimumab expression.
[0016] Step 3: Suspension culture of adalimumab overexpressing monoclonal cells, adding leupeptin stock solution on day 0 of suspension culture to make the final concentration of leupeptin 30 μM to 360 μM, and suspension culture for 7 to 10 days.
[0017] The conditions for suspension culture of adalimumab high-expressing monoclonal cells were: rotation speed 120 rpm, temperature 37° C., and CO 2 volume fraction 5%.
[0018] Compared with the prior art, the present invention has the following beneficial effects: the present invention provides a serum-free medium additive for improving the expression of recombinant antibodies in CHO cells, namely, leupeptin. The addition of leupeptin increases the expression of recombinant antibodies without affecting the normal growth ability of cells, thereby improving production efficiency and reducing the production cost of biological products. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 : is the effect of different concentrations of leupeptin on the expression of CHO cells in the present invention, a is the expression level of adalimumab detected by Western blot, and b is the relative expression level of adalimumab ADL expressed as single cell yield.
[0020] Figure 2 : The effects of different concentrations of leupeptin on the viable cell density and viability of CHO cells of the present invention, a is the statistics of viable cell density, and b is the statistics of cell viability. DETAILED DESCRIPTION
[0021] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.
[0022] The leupeptin in the following examples was purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.
[0023] DMEM / F-12 medium and CHO Pro Exp serum-free medium were purchased from Henan Punuoyi Biological Products Research Institute Co., Ltd.
[0024] The adalimumab cell line is a high-expression adalimumab clonal cell line independently constructed based on the CHO-S cell line, namely ADL-HL. The construction method is derived from the reference "Yang, Y., Li, Z., Li, Q. et al. Increase recombinant antibody yields through optimizing vector design and production process in CHO cells. Appl Microbiol Biotechnol 106, 4963–4975 (2022). https: / / doi.org / 10.1007 / s00253-022-12051-5".
[0025] Preparation of leupeptin mother solution: Take leupeptin powder and dissolve it in pure water. After it is fully dissolved, a solution with a concentration of 10 mM is obtained, and the solution is sterilized by filtering with a 0.22 μm pore size filter membrane to obtain a mother solution. The leupeptin used in the following examples is diluted from this mother solution.
[0026] Example 1
[0027] A method for increasing the expression of recombinant antibodies in CHO cells, comprising the following steps:
[0028] Step 1: Cell recovery. Take out the frozen adalimumab overexpressing monoclonal cell line, thaw quickly in a 37°C water bath, transfer the cells to a 1.5mL EP tube in a clean bench, centrifuge at 1000rpm for 5 minutes at room temperature, discard the supernatant, add 1mL of DMEM / F12 complete medium, blow evenly to form a single cell suspension, and add the cell suspension to a 25cm 2 Add 2 mL of complete culture medium to the cell culture flask, shake evenly, and then culture in a cell culture incubator at 37° C. and 5% CO 2 by volume.
[0029] Step 2: Cell adherence culture. The cells are cultured in a culture flask. When the cells grow to cover 80% of the bottom of the culture flask, they are subcultured. The old culture medium is discarded in a clean bench, and PBS is added to rinse twice. After adding trypsin to fully digest, fresh complete culture medium is added to terminate digestion, and the cells are blown evenly. The cell suspension is inoculated into a new cell culture flask at a ratio of 1:3 for subculture.
[0030] Step 3: Cell suspension culture. Observe the cell status under a microscope. When the cells are full, wash the cells with PBS, digest with trypsin, centrifuge at 1000 rpm for 5 minutes to collect the cell precipitate, add CHO cell serum-free medium to resuspend, and adjust the cell density to 4×10 5 cell / mL, added into a six-well cell culture plate at 4 mL / well, and placed on a shaker. The cell culture parameters were set as follows: rotation speed 120 rpm, temperature 37 °C, CO2 content 5%, and suspension culture was performed. The day of cell inoculation was designated as day 0 of suspension culture.
[0031] On the 0th day of suspension culture, leupeptin stock solution was added to make the final concentration of leupeptin 30 μM. The suspension culture was carried out for 7 days. Samples were taken every day during the culture process, and the cells were stained with 0.08% trypan blue by mass fraction. The live cell density and cell viability were recorded. All cells were collected on the 7th day, and the supernatant was collected by centrifugation at 1000 rpm. The expression level of adalimumab was detected by Western blot.
[0032] Example 2
[0033] A method for increasing the expression of recombinant antibodies in CHO cells, comprising the following steps:
[0034] Step 1: Cell recovery. Take out the frozen adalimumab overexpressing monoclonal cell line, thaw quickly in a 37°C water bath, transfer the cells to a 1.5mL EP tube in a clean bench, centrifuge at 1000rpm for 5 minutes at room temperature, discard the supernatant, add 1mL of DMEM / F12 complete medium, blow evenly to form a single cell suspension, and add the cell suspension to a 25cm 2 Add 2 mL of complete culture medium to the cell culture flask, shake evenly, and then culture in a cell culture incubator at 37° C. and 5% CO 2 by volume.
[0035] Step 2: Cell adherence culture. The cells are cultured in a culture flask. When the cells grow to cover 80% of the bottom of the culture flask, they are subcultured. The old culture medium is discarded in a clean bench, and PBS is added to rinse twice. After adding trypsin to fully digest, fresh complete culture medium is added to terminate digestion, and the cells are blown evenly. The cell suspension is inoculated into a new cell culture flask at a ratio of 1:3 for subculture.
[0036] Step 3: Cell suspension culture. Observe the cell status under a microscope. When the cells are full, wash the cells with PBS, digest with trypsin, centrifuge at 1000 rpm for 5 minutes to collect the cell precipitate, add CHO cell serum-free medium to resuspend, and adjust the cell density to 4×10 5cell / mL, added into a six-well cell culture plate at 4 mL / well, and placed on a shaker. The cell culture parameters were set as follows: rotation speed 120 rpm, temperature 37 °C, CO2 content 5%, and suspension culture was performed. The day of cell inoculation was designated as day 0 of suspension culture.
[0037] On the 0th day of suspension culture, leupeptin stock solution was added to make the final concentration of leupeptin 60 μM. The suspension culture was carried out for 7 days. Samples were taken every day during the culture process, and the cells were stained with 0.08% trypan blue by mass fraction. The live cell density and cell viability were recorded. All cells were collected on the 7th day, and the supernatant was collected by centrifugation at 1000 rpm. The expression level of adalimumab was detected by Western blot.
[0038] Example 3
[0039] A method for increasing the expression of recombinant antibodies in CHO cells, comprising the following steps:
[0040] Step 1: Cell recovery. Take out the frozen adalimumab overexpressing monoclonal cell line, thaw quickly in a 37°C water bath, transfer the cells to a 1.5mL EP tube in a clean bench, centrifuge at 1000rpm for 5 minutes at room temperature, discard the supernatant, add 1mL of DMEM / F12 complete medium, blow evenly to form a single cell suspension, and add the cell suspension to a 25cm 2 Add 2 mL of complete culture medium to the cell culture flask, shake evenly, and then culture in a cell culture incubator at 37° C. and 5% CO 2 by volume.
[0041] Step 2: Cell adherence culture. The cells are cultured in a culture flask. When the cells grow to cover 80% of the bottom of the culture flask, they are subcultured. The old culture medium is discarded in a clean bench, and PBS is added to rinse twice. After adding trypsin to fully digest, fresh complete culture medium is added to terminate digestion, and the cells are blown evenly. The cell suspension is inoculated into a new cell culture flask at a ratio of 1:3 for subculture.
[0042] Step 3: Cell suspension culture. Observe the cell status under a microscope. When the cells are full, wash the cells with PBS, digest with trypsin, centrifuge at 1000 rpm for 5 minutes to collect the cell precipitate, add CHO cell serum-free medium to resuspend, and adjust the cell density to 4×10 5 cell / mL, added into a six-well cell culture plate at 4 mL / well, and placed on a shaker. The cell culture parameters were set as follows: rotation speed 120 rpm, temperature 37 °C, CO2 content 5%, and suspension culture was performed. The day of cell inoculation was designated as day 0 of suspension culture.
[0043] On the 0th day of suspension culture, leupeptin stock solution was added to make the final concentration of leupeptin 120 μM. The suspension culture was carried out for 7 days. Samples were taken every day during the culture process, and the cells were stained with 0.08% trypan blue by mass fraction. The live cell density and cell viability were recorded. All cells were collected on the 7th day, and the supernatant was collected by centrifugation at 1000 rpm. The expression level of adalimumab was detected by Western blot.
[0044] Example 4
[0045] A method for increasing the expression of recombinant antibodies in CHO cells, comprising the following steps:
[0046] Step 1: Cell recovery. Take out the frozen adalimumab overexpressing monoclonal cell line, thaw quickly in a 37°C water bath, transfer the cells to a 1.5mL EP tube in a clean bench, centrifuge at 1000rpm for 5 minutes at room temperature, discard the supernatant, add 1mL of DMEM / F12 complete medium, blow evenly to form a single cell suspension, and add the cell suspension to a 25cm 2 Add 2 mL of complete culture medium to the cell culture flask, shake evenly, and then culture in a cell culture incubator at 37° C. and 5% CO 2 by volume.
[0047] Step 2: Cell adherence culture. The cells are cultured in a culture flask. When the cells grow to cover 80% of the bottom of the culture flask, they are subcultured. The old culture medium is discarded in a clean bench, and PBS is added to rinse twice. After adding trypsin to fully digest, fresh complete culture medium is added to terminate digestion, and the cells are blown evenly. The cell suspension is inoculated into a new cell culture flask at a ratio of 1:3 for subculture.
[0048] Step 3: Cell suspension culture. Observe the cell status under a microscope. When the cells are full, wash the cells with PBS, digest with trypsin, centrifuge at 1000 rpm for 5 minutes to collect the cell precipitate, add CHO cell serum-free medium to resuspend, and adjust the cell density to 4×10 5 cell / mL, added into a six-well cell culture plate at 4 mL / well, and placed on a shaker. The cell culture parameters were set as follows: rotation speed 120 rpm, temperature 37 °C, CO2 content 5%, and suspension culture was performed. The day of cell inoculation was designated as day 0 of suspension culture.
[0049] On the 0th day of suspension culture, leupeptin stock solution was added to make the final concentration of leupeptin 240 μM. The suspension culture was carried out for 7 days. Samples were taken every day during the culture process, and the cells were stained with 0.08% trypan blue by mass fraction. The live cell density and cell viability were recorded. On the 7th day, all cells were collected, and the supernatant was collected by centrifugation at 1000 rpm. The expression level of adalimumab was detected by Western blot.
[0050] Example 5
[0051] A method for increasing the expression of recombinant antibodies in CHO cells, comprising the following steps:
[0052] Step 1: Cell recovery. Take out the frozen adalimumab overexpressing monoclonal cell line, thaw quickly in a 37°C water bath, transfer the cells to a 1.5mL EP tube in a clean bench, centrifuge at 1000rpm for 5 minutes at room temperature, discard the supernatant, add 1mL of DMEM / F12 complete medium, blow evenly to form a single cell suspension, and add the cell suspension to a 25cm 2 Add 2 mL of complete culture medium to the cell culture flask, shake evenly, and then culture in a cell culture incubator at 37° C. and 5% CO 2 by volume.
[0053] Step 2: Cell adherence culture. The cells are cultured in a culture flask. When the cells grow to cover 80% of the bottom of the culture flask, they are subcultured. The old culture medium is discarded in a clean bench, and PBS is added to rinse twice. After adding trypsin to fully digest, fresh complete culture medium is added to terminate digestion, and the cells are blown evenly. The cell suspension is inoculated into a new cell culture flask at a ratio of 1:3 for subculture.
[0054] Step 3: Cell suspension culture. Observe the cell status under a microscope. When the cells are full, wash the cells with PBS, digest with trypsin, centrifuge at 1000 rpm for 5 minutes to collect the cell precipitate, add CHO cell serum-free medium to resuspend, and adjust the cell density to 4×10 5 cell / mL, added into a six-well cell culture plate at 4 mL / well, and placed on a shaker. The cell culture parameters were set as follows: rotation speed 120 rpm, temperature 37 °C, CO2 content 5%, and suspension culture was performed. The day of cell inoculation was designated as day 0 of suspension culture.
[0055] On the 0th day of suspension culture, leupeptin stock solution was added to make the final concentration of leupeptin 360 μM. The suspension culture was carried out for 7 days. Samples were taken every day during the culture process, and the cells were stained with 0.08% trypan blue by mass fraction. The live cell density and cell viability were recorded. All cells were collected on the 7th day, and the supernatant was collected by centrifugation at 1000 rpm. The expression level of adalimumab was detected by Western blot.
[0056] Comparative Example 1
[0057] A method for increasing the expression of recombinant antibodies in CHO cells, comprising the following steps:
[0058] Step 1: Cell recovery. Take out the frozen adalimumab overexpressing monoclonal cell line, thaw quickly in a 37°C water bath, transfer the cells to a 1.5mL EP tube in a clean bench, centrifuge at 1000rpm for 5 minutes at room temperature, discard the supernatant, add 1mL of DMEM / F12 complete medium, blow evenly to form a single cell suspension, and add the cell suspension to a 25cm 2 Add 2 mL of complete culture medium to the cell culture flask, shake evenly, and then culture in a cell culture incubator at 37° C. and 5% CO 2 by volume.
[0059] Step 2: Cell adherence culture. The cells are cultured in a culture flask. When the cells grow to cover 80% of the bottom of the culture flask, they are subcultured. The old culture medium is discarded in a clean bench, and PBS is added to rinse twice. After adding trypsin to fully digest, fresh complete culture medium is added to terminate digestion, and the cells are blown evenly. The cell suspension is inoculated into a new cell culture flask at a ratio of 1:3 for subculture.
[0060] Step 3: Cell suspension culture. Observe the cell status under a microscope. When the cells are full, wash the cells with PBS, digest with trypsin, centrifuge at 1000 rpm for 5 minutes to collect the cell precipitate, add CHO cell serum-free medium to resuspend, and adjust the cell density to 4×10 5 cell / mL, added into a six-well cell culture plate at 4 mL / well, and placed on a shaker. The cell culture parameters were set as follows: rotation speed 120 rpm, temperature 37 °C, CO2 content 5%, and suspension culture was performed. The day of cell inoculation was designated as day 0 of suspension culture.
[0061] The cells were suspended and cultured for 7 days. Samples were taken every day during the culture process. The cells were stained with 0.08% trypan blue. The live cell density and cell viability were recorded. All cells were collected on the 7th day, and the supernatant was collected by centrifugation at 1000 rpm. The expression of adalimumab was detected by Western blot.
[0062] According to the test results of Examples 1 to 5 and Control Example 1, 30 μM to 360 μM of leupeptin can increase the expression of adalimumab ADL in CHO cells. Figure 1 The optimal concentration of leupeptin was 60 μM, which increased the relative expression level of ADL by 1.76 times. Figure 2 It can be seen that compared with the control group, leupeptin had no significant effect on cell growth. Figure 1 b was processed by ImageJ Figure 1 The relative expression of ADL was obtained by gray value analysis of the Western blot band of a. The relative expression level of ADL represents the specific productivity of the cell, i.e., Qp.
[0063] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0064] The above-mentioned embodiments only express several implementation methods of the present invention, and the description is relatively specific and detailed, but it cannot be understood as limiting the scope of the invention patent. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A serum-free medium additive for improving the expression of recombinant antibodies in CHO cells, characterized in that: The additive is leupeptin, and its final concentration in serum-free culture medium is 30 μM to 360 μM.
2. The serum-free medium additive for improving the expression of recombinant antibodies in CHO cells according to claim 1, characterized in that: The serum-free medium is any one of CHO Pro Exp serum-free medium, HyCell CHO Medium and EXCELL CHO Fusion.
3. The use of the serum-free medium additive according to claim 1, characterized in that: The leupeptin is used to increase the expression level of biological products in CHO cells, and the biological products are recombinant vaccines or recombinant antibodies.
4. The use of the serum-free medium additive according to claim 1, characterized in that: Compared with the control without the addition of leupeptin, the addition of leupeptin increased the relative expression level of the CHO cell biological product by more than 1.76 times.
5. The use of the serum-free medium additive according to claim 1, characterized in that: The leupeptin was added on day 0 of the CHO cell suspension culture.
6. The use of the serum-free medium additive according to claim 1, characterized in that: When CHO cells are cultured in suspension, the concentration of leupeptin in the serum-free culture medium is 30 μM to 360 μM.
7. The use of the serum-free medium additive according to claim 6, characterized in that: The concentration of leupeptin is 30 μM to 120 μM.
8. The use of the serum-free medium additive according to claim 3, characterized in that: The CHO cell recombinant antibody is adalimumab.
9. The use of the serum-free medium additive according to claim 8, characterized in that: The method for increasing the expression level of adalimumab in CHO cells comprises the following steps: Step 1: Cell recovery of adalimumab high-expressing monoclonal cell line; Step 2: Adhesion culture of adalimumab high-expressing monoclonal cells; Step 3: Suspension culture of adalimumab overexpressing monoclonal cells, adding leupeptin stock solution on day 0 of suspension culture to make the final concentration of leupeptin 30 μM to 360 μM, and suspension culture for 7 to 10 days.
10. The use of the serum-free medium additive according to claim 9, characterized in that: The conditions for suspension culture of monoclonal cells with high expression of Damu are: The rotation speed is 120 rpm, the temperature is 37°C, and the CO2 volume fraction is 5%.
